Physician profile
Chenyu Tan
NPI 1538908645
$672.77
in general payments reported to CMS, 2019-2025
9 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $172 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $224.03 | 2024-2025 | Valtoco |
| Ucb, INC. | $183.31 | 2024-2025 | Nayzilam, Fintepla, Briviact |
| Aucta Pharmaceuticals, INC. | $98.36 | 2024-2025 | Motpoly Xr |
| Biocodex, INC. | $42.27 | 2025 | |
| Otter Pharmaceuticals, LLC | $38.88 | 2025 | Sympazan |
| Azurity Pharmaceuticals, INC. | $33.86 | 2024-2025 | Zonisade |
| Jazz Pharmaceuticals INC. | $22.39 | 2025 | |
| Sk Life Science, INC. | $15.87 | 2024 | |
| Aquestive Therapeutics, INC. | $13.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chenyu Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.